{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:22:07Z","timestamp":1777576927197,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.09.008","type":"journal-article","created":{"date-parts":[[2007,9,21]],"date-time":"2007-09-21T11:13:34Z","timestamp":1190373214000},"page":"7873-7884","source":"Crossref","is-referenced-by-count":29,"title":["Escheriosome-mediated delivery of recombinant ribosomal L7\/L12 protein confers protection against murine brucellosis"],"prefix":"10.1016","volume":"25","author":[{"given":"A.I.","family":"Mallick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Singha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Owais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.09.008_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinids\/21.2.283","article-title":"An overview of human brucellosis","volume":"21","author":"Yang","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.008_bib2","first-page":"631","article-title":"Contributions of biotechnology to the control and prevention of brucellosis in Africa","volume":"3","author":"Henk","year":"2004","journal-title":"Afr J Biotechnol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(50)90408-9","article-title":"Undulant fever: a neglected problem","volume":"1","author":"Dalrymple-Champneys","year":"1950","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.09.008_bib4","volume":"vols. 1 and 2","author":"USBWP, Department of the Army","year":"1977"},{"key":"10.1016\/j.vaccine.2007.09.008_bib5","series-title":"Brucellosis: clinical and laboratory aspects","first-page":"41","article-title":"Relationship between animal and human disease","author":"Nicoletti","year":"1989"},{"key":"10.1016\/j.vaccine.2007.09.008_bib6","unstructured":"WHO Report. Report of WHO meeting, WHO\/EMC\/ZDI\/98. Geneva, Switzerland: WHO; December 11\u201312, 1997. p. 14\u20135."},{"key":"10.1016\/j.vaccine.2007.09.008_bib7","first-page":"1192","article-title":"Rev-1 Brucella meletensis vaccine. Part III (1981\u20131995)","volume":"66","author":"Elberg","year":"1996","journal-title":"Vet Bull"},{"key":"10.1016\/j.vaccine.2007.09.008_bib8","series-title":"Brucella: molecular and cellular biology","first-page":"369","article-title":"Development of new Brucella vaccines by molecular methods","author":"Hoover","year":"2004"},{"key":"10.1016\/j.vaccine.2007.09.008_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats","volume":"31","author":"Blasco","year":"2002","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2007.09.008_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","article-title":"Biological properties of RB51: a stable rough strain of Brucella abortus","volume":"28","author":"Schurig","year":"1991","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1073\/pnas.221575398","article-title":"The genome sequence of the facultative intracellular pathogen Brucella melitensis","volume":"99","author":"DelVecchio","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.09.008_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/IAI.13.2.311-321.1976","article-title":"Immunization by an insoluble fraction extracted from Brucella meletensis: immunological and chemical characterization of the active substances","volume":"13","author":"Lopez Merino","year":"1976","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.008_bib14","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or p39 recombinant protein with CPG oligonucleotides as adjuvants","volume":"69","author":"Al-marari","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.008_bib15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0264-410X(94)90035-3","article-title":"Modulation of immune response in Balb\/c mice vaccinated with Brucella abortus Cu\u2013Zn superoxide dismutase synthetic peptide vaccine","volume":"12","author":"Tabatabai","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.008_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CDLI.7.1.114-118.2000","article-title":"Characterization of specific immune response of mice inoculated with recombinant vaccine virus expressing an 18-kilodalton outer membrane protein of Brucella abortus","volume":"7","author":"Vemulapalli","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib17","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1128\/IAI.62.12.5361-5366.1994","article-title":"Brucella ribosomal protein L7\/L12 is a major component in antigenicity of brucellin INRA for delayed-type hypersensitivity in Brucella sensitized guinea pigs","volume":"62","author":"Bachrach","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.008_bib18","first-page":"37","article-title":"Sequences of the rpIJL operon containing the L10 and L7\/L12 genes from Brucella abortus","volume":"140","author":"Oliveria","year":"1992","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2007.09.008_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveria","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.008_bib20","first-page":"659","article-title":"Recombinant L7\/L12 protein and gamma irradiated Brucella abortus induce a T helper 1 subset response from murine CD4+ T cells","volume":"83","author":"Oliveria","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2007.09.008_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/cimm.1996.0241","article-title":"Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs","volume":"172","author":"Oliveira","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib22","first-page":"13","article-title":"High level expression of recombinant ribosomal protein (L7\/L12) from Brucella abortus and its reaction with infected human sera","volume":"8","author":"Abtahi","year":"2004","journal-title":"Iran Biomed J"},{"key":"10.1016\/j.vaccine.2007.09.008_bib23","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity eliciated by a divalent DNA vaccine encoding both the L7\/L12 and OMP16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.008_bib24","first-page":"59","article-title":"Antigen incorporation into liposome results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th2 cells","volume":"2","author":"Agrewala","year":"1996","journal-title":"Cytokines Mol Ther"},{"key":"10.1016\/j.vaccine.2007.09.008_bib25","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1046\/j.1432-1327.2000.01447.x","article-title":"Liposome mediated cytosolic delivery of macromolecules and its possible use in vaccine development","volume":"267","author":"Owais","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2007.09.008_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3083.2001.00944.x","article-title":"Use of liposomes as an immunopotentiating delivery system: in perspective of vaccine development","volume":"54","author":"Owais","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib27","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1046\/j.0014-2956.2001.02507.x","article-title":"Fusogenic potential of prokaryotic membrane lipids: Implication in vaccine development","volume":"268","author":"Ahmad","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2007.09.008_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/cimm.2001.1805","article-title":"Liposome mediated antigen delivery leads to induction of CD8+ T lymphocyte and antibody responses against the V3 loop region of HIV gp120","volume":"210","author":"Ahmad","year":"2001","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib29","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0264-410X(03)00106-3","article-title":"Antigen entrapment in the escheriosome leads in the generation of CD+ helper and CD8+ cytotoxic T cell response","volume":"21","author":"Faisal","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.008_bib30","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2005.10.025","article-title":"Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis","volume":"24","author":"Sharma","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.008_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.vaccine.2005.08.063","article-title":"Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB\/c mice","volume":"24","author":"Sharma","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.008_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1574-6968.1995.tb07725.x","article-title":"Protective effect of brucella outer membrane complex included on liposome against experimental murine brucellosis","volume":"130","author":"Vitas","year":"1995","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2007.09.008_bib33","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.vaccine.2007.01.066","article-title":"Liposomised recombinant ribosomal L7\/L12 protein protects BALB\/c mice against Brucella abortus 544 infection","volume":"25","author":"Mallick","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.008_bib34","unstructured":"Sambrook J, Russel DW. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor, NY 2001."},{"key":"10.1016\/j.vaccine.2007.09.008_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/303632a0","article-title":"Red cell membrane abnormalities in chronic myeloid leukemia","volume":"303","author":"Kumar","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.09.008_bib36","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/S0021-9258(19)69590-6","article-title":"Influence of changes in polar head group composition on the lipid phase transition and characterization of a mutant containing only saturated phospholipids acyl chains","volume":"268","author":"Pluschke","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.09.008_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02558256","article-title":"A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions","volume":"42","author":"Singleton","year":"1965","journal-title":"J Am Oil Chem Soc"},{"key":"10.1016\/j.vaccine.2007.09.008_bib38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nbt1184-979","article-title":"Dehydration\u2013rehydration vesicles: a simple method for high yield drug entrapment","volume":"2","author":"Kirby","year":"1984","journal-title":"Biotechnology"},{"key":"10.1016\/j.vaccine.2007.09.008_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0034-5288(18)31136-6","article-title":"Dot enzyme linked immunosorbant assay for the detection of antibodies in bovine sera","volume":"46","author":"Batra","year":"1989","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2007.09.008_bib40","series-title":"Selected methods in cellular immunology","author":"Mishell","year":"1980"},{"key":"10.1016\/j.vaccine.2007.09.008_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4049\/jimmunol.101.5.830","article-title":"Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice","volume":"101","author":"Collins","year":"1968","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1365-2672.2005.02622.x","article-title":"Bacterial. Zoonoses, statutory and exotic bacterial diseases","volume":"98","author":"Cutler","year":"2005","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0005-2736(02)00368-1","article-title":"Lysteriolysin O-liposome mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen specific cytotoxic T lymphocyte frequency, activity, and tumor protection","volume":"1563","author":"Mandal","year":"2002","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.vaccine.2007.09.008_bib44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2249.1999.00989.x","article-title":"Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine","volume":"117","author":"Polt-Frank","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/bbrc.2002.6711","article-title":"Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH sensitive liposomes encapsulated with K(b)-restricted CTL epitope","volume":"292","author":"Lee-ki","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2007.09.008_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0169-409X(01)00214-9","article-title":"Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development","volume":"52","author":"Kunisawa","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2007.09.008_bib47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0264-410X(01)00326-7","article-title":"A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains","volume":"20","author":"Babai","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.008_bib48","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.4049\/jimmunol.147.9.2860","article-title":"Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation","volume":"147","author":"Harding","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib49","series-title":"Immunology","author":"Goldsby","year":"2003"},{"key":"10.1016\/j.vaccine.2007.09.008_bib50","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1128\/IAI.60.6.2459-2464.1992","article-title":"Antigen of Brucella abortus S19 immunodominant for bovine lymphocyte as identified by one and two-dimensional cellular immunoblotting","volume":"60","author":"Brooks-Worrel","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.008_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0034-5288(18)32806-6","article-title":"Correlation of lymphocyte migration, leukocyte migration inhibition and delayed continuous hypersensitivity tests in chickens sensitized to Mycobacterium tuberculosis","volume":"27","author":"Timms","year":"1979","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2007.09.008_bib52","first-page":"493","article-title":"Two migratory inhibitory factors with different chomographic behaviour and isoelectric points","volume":"27","author":"Renold","year":"1977","journal-title":"Am J Hygiene"},{"key":"10.1016\/j.vaccine.2007.09.008_bib53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0147-9571(82)90072-8","article-title":"Inhibition of chicken leukocyte migration in vitro: a direct agarose plate assay","volume":"5","author":"Gilliiand","year":"1982","journal-title":"J Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.008_bib54","first-page":"221","article-title":"Lymphokines production on cell mediated immunity to Mareks disease","volume":"10","author":"Choll","year":"1977","journal-title":"Clin J Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib55","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cells clone. Definition according to profiles of lymphokine activities and secreted proteins","volume":"126","author":"Mossman","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.09.008_bib56","first-page":"547","article-title":"Use of phenol-soluble Brucella antigen in man as a test to detect specific skin sensitivity","volume":"56","author":"Bertrand","year":"1984","journal-title":"Dev Biol Stand"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T06:19:36Z","timestamp":1684045176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":56,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07010274"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}